Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / News / 2012 News / UNC Lineberger faculty co-author review article on adjuvant chemotherapy in women 70 years of age and older

UNC Lineberger faculty co-author review article on adjuvant chemotherapy in women 70 years of age and older

by maryruth.helms — last modified Sep 19, 2012 11:47 AM

Jones-Leak-Muss
Ellen Jones, MD; Ashley Leak, PhD, RN-BC, OCN; and Hy Muss, MD; co-authored the article.

Three UNC Lineberger faculty co-authored a review article titled “Adjuvant Therapy of Breast Cancer in Women 70 Years of Age and Older: Tough Decisions, High Stakes,” that was published in the September 12, 2012 issue of the journal Oncology.

Ellen Jones, MD, associate professor of radiation oncology; Ashley Leak, PhD, RN-BC, OCN, Cancer Care Quality Training Post-Doctoral Fellow and adjunct assistant professor in the UNC School of Nursing, and Hy Muss, MD, professor of medicine and leader of the UNC Lineberger Geriatric Oncology Program, co-authored the article.

The UNC authors’ abstract states: “In most Western nations, the incidence and mortality rates for breast cancer rise dramatically with increasing age, and in the coming decades oncologists will be faced with managing an increasing number of older patients with breast cancer. Having the knowledge and tools to optimally treat this group will be essential.

The challenge of caring for an older cancer patient is to provide treatment options that maximize long-term survival and account for life expectancy, comorbidities, and the effects of treatment on function. For example, a mild treatment-induced peripheral neuropathy can transform a functioning elder into one who is dependent on institutional care. Complicating matters, there is a paucity of data from randomized trials on the risks and benefits of our newer and increasingly effective treatments in older breast cancer patients.

In this review we will discuss how to evaluate older breast cancer patients, including estimating survival, defining functional limitations, and providing guidelines for optimal adjuvant therapies.”

Filed under: , ,